Clinical Trial Update: Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating nintedanib in combination with chemotherapy for advanced pancreatic cancer was terminated, with results posted in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cancer of Pancreas | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-03